References
- World Health Organization. Global Health Observatory on Hypertension. Available at: http://www.who.int. Last accessed 10 Sept 2014
- Katzung B (ed.) Basic & Clinical Pharmacology, 9th edn. New York: McGraw-Hill, 2004
- Ram CV. Hypertension, possible vascular protection and lercanidipine. Expert Rev Cardiovasc Ther 2006;4:783-8
- Liu L. 2010 Chinese guidelines for the management of hypertension. Zhongua Xin Xue Guan Bing Za Zhi 2011;39:579-615
- Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60
- Niiranen TJ, Maki J, Puukka P, et al. Office, home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension 2014, epub ahead of print, DOI: 10.1161/HYPERTENSIONAHA.114.03292 (unpublished)
- Policicchio D, Magliocca R, Malliani A. Efficacy and tolerability of lercanidipine in patients with mild to moderate essential hypertension: a comparative study with slow-release nifedipine. J Cardiovasc Pharm 1997;29(Suppl 2):S31-5
- Angelico P, Guarneri L, Leonardi A, et al. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues. J Pharm Pharmacol 1999;51:709-14
- Romito R, Pansini MI, Perticone F, et al. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study. J Clin Hypertens (Greenwich) 2003;5:249-53
- Borghi C, Prandin MG, Dormi A, et al; Study Group of the Regional Unit of the Italian Society of Hypertension. Improved tolerability of the dihydropyridine calcium-channel antagonist lercanidipine: the lercanidipine challenge trial. Blood Press Suppl 2003;1:14-21
- Makarounas-Kirchmann K, Glover-Koudounas S, Ferrari P. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. Clin Ther 2009;31:1652-63
- Bang LM, Chapman TM, Goa KL. Lercanidipine: a review of its efficacy in the management of hypertension. Drugs 2003;63:2449-72